Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population

Sigrid Næss1, Benedicte A Lie2, Espen Melum3

  • 1Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Plos One
|December 19, 2014
PubMed
Abstract

Related Concept Videos